Skip to Main Content

Paper Details

Phospholipidosis is a shared mechanism underlying the in vitro antiviral activity of many repurposed drugs against SARS-CoV-2.
bioRxiv
5
2021
COVID-, COVID-19, Drug, Phospholipidosis, SARS-, SARS-CoV-2, amiodarone, azithromycin, cell culture, hydroxychloroquine, phospholipidosis
Author NameAffiliation
Tia A TumminoDepartment of Pharmaceutical Chemistry, University of California San Francisco (UCSF)
Tia A TumminoGraduate Program in Pharmaceutical Sciences and Pharmacogenomics
Tia A TumminoQuantitative Biosciences Institute (QBI)
Tia A Tummino
Veronica V RezeljInstitut Pasteur, CNRS UMR 3569
Benoit FischerNovartis Institutes for BioMedical Research, Preclinical Safety
Audrey FischerNovartis Institutes for BioMedical Research, Preclinical Safety
Matthew J O'MearaUniversity of Michigan ann arbor
Blandine MonelInstitut Pasteur, CNRS UMR 3569
Thomas ValletInstitut Pasteur, CNRS UMR 3569
Ziyang ZhangQuantitative Biosciences Institute (QBI)
Ziyang Zhang
Ziyang Zhang
Ziyang ZhangHoward Hughes Medical Institute
Assaf AlonBlavatnik Institute, Harvard Medical School
Henry R O'DonnellDepartment of Pharmaceutical Chemistry, University of California San Francisco (UCSF)
Jiankun LyuDepartment of Pharmaceutical Chemistry, University of California San Francisco (UCSF)
Jiankun LyuQuantitative Biosciences Institute (QBI)
Jiankun Lyu
Heiko S SchadtNovartis Institutes for BioMedical Research, Preclinical Safety
Kris M WhiteIcahn School of Medicine at Mount Sinai
Kris M WhiteGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Nevan J Krogan (CM4AI)Quantitative Biosciences Institute (QBI)
Nevan J Krogan (CM4AI)
Nevan J Krogan (CM4AI)
Nevan J Krogan (CM4AI)Icahn School of Medicine at Mount Sinai
Nevan J Krogan (CM4AI)Gladstone Institute of Data Science and Biotechnology, J. David Gladstone Institutes
Laszlo UrbanNovartis Institutes for BioMedical Research, Preclinical Safety
Kevan M ShokatQuantitative Biosciences Institute (QBI)
Kevan M Shokat
Kevan M Shokat
Kevan M ShokatHoward Hughes Medical Institute
Andrew C KruseBlavatnik Institute, Harvard Medical School
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai
Adolfo Garc??a-SastreGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai
Adolfo Garc??a-SastreTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Olivier SchwartzInstitut Pasteur, CNRS UMR 3569
Marco VignuzziInstitut Pasteur, CNRS UMR 3569
Francois PognanNovartis Institutes for BioMedical Research, Preclinical Safety
Brian K ShoichetDepartment of Pharmaceutical Chemistry, University of California San Francisco (UCSF)
Brian K ShoichetQuantitative Biosciences Institute (QBI)
Brian K Shoichet
Brian K ShoichetDepartment of Pharmaceutical Chemistry, University of California San Francisco (UCSF)
Brian K ShoichetQuantitative Biosciences Institute (QBI)
Brian K Shoichet
  • 1 - 46

Datasets